logo

Novavax begins phase 2 COVID-19 vaccine trials in South Africa

American vaccine group Novavax has begun its phase 2 clinical trials in South Africa this week, this trial is supported in part by a $15 million grant from the Bill & Melinda Gates Foundation and will be led by Dr. Shabir Madhi, Professor of Vaccinology at Wits University. Dr. Shabir Madhi joins CNBC Africa for more.


Wed Aug 19 2020 | 11:45:29 GMT+0000 (Coordinated Universal Time)

Share

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.